Wegovy® (semaglutide injection) — 0.5 mg
- Medicare
- Priced November 22, 2026
Your cheapest verified route right now
verified price- Per year at 12 fills
- $600
What the climb costs
- 0.25 mg 9×
- 0.5 mg 4×
- Jan 1 Retail list price (reference) — Wegovy® (semaglutide injection) moves to $675/month
- Already priced into the totals above — each fill uses the price in force on its own date. See the changelog
Fills at each dose on the way up
Reset to the label minimumMinus stops at the label's minimum interval — this never shows a schedule faster than the manufacturer's. Staying longer on a dose is yours to choose.
Every fill, dated and priced (13)
- 1 Nov 22, 2026 0.25 mg Medicare GLP-1 Bridge $50
- 2 Dec 20, 2026 0.25 mg Medicare GLP-1 Bridge $50
- 3 Jan 17, 2027 0.25 mg Medicare GLP-1 Bridge $50
- 4 Feb 14, 2027 0.25 mg Medicare GLP-1 Bridge $50
- 5 Mar 14, 2027 0.25 mg Medicare GLP-1 Bridge $50
- 6 Apr 11, 2027 0.25 mg Medicare GLP-1 Bridge $50
- 7 May 9, 2027 0.25 mg Medicare GLP-1 Bridge $50
- 8 Jun 6, 2027 0.25 mg Medicare GLP-1 Bridge $50
- 9 Jul 4, 2027 0.25 mg Medicare GLP-1 Bridge $50
- 10 Aug 1, 2027 0.5 mg Medicare GLP-1 Bridge $50
- 11 Aug 29, 2027 0.5 mg Medicare GLP-1 Bridge $50
- 12 Sep 26, 2027 0.5 mg Medicare GLP-1 Bridge $50
- 13 Oct 24, 2027 0.5 mg Medicare GLP-1 Bridge $50
The label's own words (once weekly)
Table 1 of the prescribing information: 0.25 mg once weekly for weeks 1 through 4, 0.5 mg for weeks 5 through 8, 1 mg for weeks 9 through 12, 1.7 mg for weeks 13 through 16, and the maintenance dosage from week 17 onward. If a dose is not tolerated during escalation, the label says escalation may be delayed by 4 weeks. The 7.2 mg strength (Wegovy HD) is approved for weight reduction in adults only, and the label reaches it only after at least 4 weeks of tolerating 2.4 mg.
Verified Oct 19, 2026 ·novo-pi.com
Every route we can price
Verified prices outrank cheaper estimates. Reference rows inform, never win.
- Rank 1
Medicare GLP-1 Bridge
until Dec 31, 2027$50/mo- All Wegovy formulations covered, injection and tablets
- Pen needles are not covered — buy them separately
- Runs OUTSIDE the Part D plan (central processor: Humana, BIN 028918 / PCN MEDDGLP1BR). Not available if your Part D plan already covers a GLP-1 for you, or if you have T2D, moderate-to-severe OSA, or noncirrhotic MASH (those route through standard Part D). Filling any GLP-1 through your Part D plan after you are approved ends your Bridge eligibility for good — the next Bridge refill is rejected at the counter — and so does moving to a Part D plan type the Bridge does not cover. Which types those are: the Bridge reaches a standalone drug plan (PDP), a Medicare Advantage coordinated care plan with drug coverage (HMO, HMOPOS, and Local and Regional PPO), a Special Needs Plan, an employer or union group waiver plan, and LI NET. It does NOT reach a private fee-for-service plan, a section 1876 cost contract, a section 1833 health care prepayment plan, PACE, a fallback plan or a religious fraternal benefit plan — in one of those you are ineligible however well you meet the clinical criteria, unless you are also enrolled in a standalone PDP. A prescriber must attest on the prior authorization that you met a BMI category: BMI >= 35; or >= 30 with heart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease stage 3a or above; or >= 27 with pre-diabetes, prior myocardial infarction, prior stroke, or symptomatic peripheral artery disease. That BMI is the one you had when you STARTED GLP-1 therapy, not the one you have now — losing weight since does not disqualify you. The copay does not count toward the Part D deductible or your out-of-pocket maximum, and no coupons apply. There is no low-income subsidy — LIS beneficiaries pay it in full.
Verified Oct 18, 2026 · cms.gov
- Rank 2
Discount card at retail (GoodRx and similar)
$349/mointro
offer GoodRx introductory cash price: first 2 fills at $199/month, then $349. New patients, which Novo defines as patients who have not redeemed any other GoodRx coupon for Wegovy injection. Covers the 0.25 mg and 0.5 mg starting doses only — every higher dose is the standing $349 from the first fill, and the third fill reverts to it. Self-pay only: no insurance of any kind may be used, and the cost may not be applied to a deductible or to Part D true out-of-pocket. GoodRx announced the offer on 2025-11-17 in partnership with Novo Nordisk; this row starts on the day the corpus begins tracking this route's standing price, because an introductory price has nothing to discount before then. Offer ends Dec 31, 2026.- Novo's standard self-pay offer price, listed by NDC for every injection dose from 0.25 mg to 2.4 mg; a two-month supply is $698 and three is $1,047
- Dose- and pharmacy-dependent. Verify at your ZIP before relying on it.
Verified Oct 21, 2026 · grxstatic.com
- Rank 3
NovoCare Pharmacy self-pay
$349/mointro
offer NovoCare introductory offer: first 2 fills at $199/month, then $349. Patients new to NovoCare Pharmacy. Covers the 0.25 mg and 0.5 mg starting doses only — every higher dose is the standing price from the first fill. Offer ends Dec 31, 2026.- Novo's direct channel. Free home delivery. Intro offers for new patients are time-limited.
Verified Oct 14, 2026 · novocare.com
TrumpRx
reference verify locally$199/mo- Mirrors the NovoCare intro offer; ongoing price $349
- Government referral site — does not sell drugs or process payments; issues coupons or routes to manufacturer DTC channels. Every figure it shows is a starting-at price — the site's own column is headed 'Lowest' — so it is a floor for the cheapest dose or intro offer, never a flat price.
Verified Oct 14, 2026 · trumprx.gov
Retail list price (reference)
reference verify locally until Dec 31, 2026$1,349/mo- Context anchor only — what the drug costs with no route at all. Walk-in cash at retail typically exceeds WAC.
Verified Oct 14, 2026 · trumprx.gov